Find stats on top websites
Biocogniv is a digital diagnostics company that leverages artificial intelligence and laboratory data to improve patient outcomes in acute care settings. Their flagship product, Sepsis aiMarker™, helps detect sepsis up to 72 hours in advance using routine blood tests. The company has received FDA Breakthrough Designation for this product, demonstrating its potential to transform sepsis diagnosis and management.
Company : Biocogniv
Industry : Digital DiagnosticsArtificial IntelligenceHealthcare
Biocogniv Key Value propositions
Biocogniv Latest news
Biocogniv Closes $6M in Seed Funding Led By Breyer Capital to ...
Mar 16, 2022 ... Biocogniv Closes $6M in Seed Funding Led By Breyer ... top of laboratory data, today announced the ... Our PapersNewsAbout UsContact. Copyright ...
Biocogniv Inc | LinkedIn
Nov 19, 2023 ... https://biocogniv.com. External link for ... This is a major milestone for our tiny team of ... View all updates, news, and articles. Join ...
Biocogniv Receives FDA Breakthrough Designation for Sepsis ...
Apr 7, 2023 ... Biocogniv Inc is the world's first digital diagnostic company tackling time-critical conditions using artificial intelligence on top of ...
Artur Adib - Biocogniv Inc | LinkedIn
ShellJS.org: top 100 NodeJS package, downloaded more than 5 million times per month * StrapdownJS.com: over 1,000 stars on Github
Biocogniv SWOT Analysis
Strengths
FDA Breakthrough Designation for Sepsis aiMarker™AI-powered technology for early sepsis detectionIntegration with existing hospital systems
Weaknesses
Relatively new company with limited market presenceFocus on a single product (Sepsis aiMarker™)Dependence on adoption by healthcare professionals
Opportunities
Expanding product line to address other acute conditionsStrategic partnerships with healthcare providers and payersGrowing market for AI-driven healthcare solutions
Threats
Competition from established players in diagnostics and AIRegulatory hurdles and data privacy concernsPotential for biased algorithms or inaccurate results
Top Marketing Strategies for Biocogniv
Biocogniv User Persona
Name:
Age :
Gender :
Occupation :
Industry :
Education :
Preferred platforms
GOALS
Frustrations
Biocogniv Geographic and Demographic Insights
Geographic Insights: The United States is the primary market with 60% of users, followed by the United Kingdom (15%) and Germany (10%). Canada and Australia represent significant but smaller markets.
United States
60%
United Kingdom
15%
Germany
10%
Canada
7.5%
Australia
7.5%
Demographic Insights: Target users are mainly between 35-54, representing experienced medical professionals. Slight male preference (55%) aligns with leadership roles in healthcare.
Biocogniv Socio-economic Profile
Household and Income Insights: Target users are primarily middle to high income earners, reflecting the demographics of healthcare professionals and hospital administrators.
Educational and Employment Insights: Target users are highly educated with at least a university degree, employed primarily in full-time roles within the healthcare industry.
Biocogniv Behavioral Insights
Interest-Based Insights: Users are interested in healthcare technology, particularly in AI and data analytics, reflecting their desire to improve patient care and hospital management.
Technology and Social Media Usage: Users prefer professional platforms like LinkedIn for information. They predominantly use desktops, reflecting their work environment.
Biocogniv Top Competitors
Competitor | Estimated market share | Top domains |
---|---|---|
Tempus | 40% | Artificial Intelligence, Precision Medicine, Data Analytics |
PathAI | 30% | Computational Pathology, AI-Powered Diagnostics, Drug Development |
Paige | 20% | Digital Pathology, AI for Oncology, Clinical Decision Support |